Urothelial Carcinoma
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-04Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 trial investigating pembrolizumab (MK-3475) after surgery for localized muscle-invasive bladder cancer and locally advanced urotheli…
-
CLINICAL_TRIALS trial_result · 2026-08-03Clinical Trial Results: Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC) [Phase 1, Phase 2]
Results from a Phase 1/2 study evaluating several immunotherapy-based treatments and combinations in patients with urothelial carcinoma (bla…
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 trial results of NUC-3373 in combination with other agents in patients with advanced solid tumors; study status terminated with re…
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 clinical trial evaluating pembrolizumab after surgery for localized muscle-invasive bladder cancer and locally advanced urothelial c…
-
CLINICAL_TRIALS trial_result · 2026-07-01Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 trial investigating pembrolizumab after surgery for localized muscle-invasive bladder cancer and locally advanced urothelial carcino…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 trial investigating pembrolizumab (MK-3475) after surgery for localized muscle-invasive bladder cancer and locally advanced urotheli…
-
CLINICAL_TRIALS trial_result · 2026-06-12Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 trial evaluating pembrolizumab (MK-3475) after surgery for localized muscle-invasive bladder cancer and locally advanced urothelial …
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Efficacy and Utility of Cxbladder Tests in Hematuria Patients
A completed clinical trial assessing the efficacy and utility of the Cxbladder diagnostic test in patients presenting with hematuria, with r…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley) [Phase 2]
Phase 2 trial evaluating various combinations of avelumab in locally advanced or metastatic urothelial carcinoma; the study is currently act…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma [Phase 3]
Phase 3 study evaluating tislelizumab in combination with chemotherapy versus chemotherapy alone for urothelial carcinoma is currently activ…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies [Phase 1]
Phase 1 trial of AUR106 in relapsed advanced malignancies has been terminated; the document provides a status update on this study.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
Expanded-access treatment program for the investigational gene therapy Cretostimogene Grenadanorepvec to treat non-muscle-invasive bladder c…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer [Phase 2]
This Phase 2 trial update tests atezolizumab with or without eribulin mesylate in patients with recurrent locally advanced or metastatic uro…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial evaluating BMS-986340 as monotherapy and in combination with nivolumab or docetaxel across several advanc…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
The document reports the completion of a non-interventional study evaluating avelumab in patients with advanced or metastatic urothelial car…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer [Phase 2]
Phase 2 study evaluating sacituzumab govitecan as neoadjuvant therapy before radical cystectomy for muscle-invasive bladder cancer has compl…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma [Phase 1]
Phase 1 clinical trial evaluating dual-target Nectin-4/HER2 CAR-NK cells for advanced urothelial carcinomas, including bladder cancer, is cu…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy [Phase 3]
Phase 3 trial update evaluating the optimal duration of immune checkpoint therapy for locally advanced and metastatic urothelial carcinoma; …
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Bristol Bladder Trial [Phase 2]
Phase 2 Bristol bladder trial completed with results posted, evaluating a treatment for infiltrating bladder urothelial carcinoma.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating STRO-004 in adults with refractory or recurrent metastatic cancer is currently recruiting, investigating…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: PRO1107 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
The Phase 1/2 PRO1107 trial in advanced solid tumors, including endometrial and ovarian cancers, has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors [Phase 1]
A Phase 1 trial assessing IMP321 (eftilagimod alpha) for advanced solid tumors reports feasibility and safety findings.
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America
The study, completed in Latin America, characterizes the clinical-pathological features and outcomes of patients with recurrent or metastati…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers [Phase 1]
Adaptimmune's Phase 1 trial of MAGE-A10 CAR T therapy for urothelial carcinoma, head and neck cancer, and melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Selinexor and Pembrolizumab for the Treatment of Cisplatin-Ineligible or Cisplatin-Refractory Locally Advanced or Metastatic Urothelial Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the combination of selinexor and pembrolizumab in cisplatin-ineligible or cisplatin-refractory locally advanced…